51ºÚÁϳԹÏÍø

Journal of Molecular Immunology
51ºÚÁϳԹÏÍø

Immunogenicity of biopharmaceuticals

Search results for
Immunogenicity of biopharmaceuticals

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

51ºÚÁϳԹÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Immunogenicity of biopharmaceuticals

Immune response by biopharmaceuticals agents are increasing greatly. The first generation of such products were of non-human origin, such as bovine-insulin, streptokinase or staphylokinase. The more recent preparations include human recombinant DNA products, such as interferon (IFN)α 2a, IFNβ, erythropoietin, insulin and growth hormone.

Related Journals of Immunogenicity of biopharmaceuticals
Journal of Molecular Immunology, Clinical & Medical Genomics 51ºÚÁϳԹÏÍø, Pharmacogenomics & Pharmacoproteomics 51ºÚÁϳԹÏÍø, Proteomics & Bioinformatics Open Access, Proteomics & Enzymology Hybrid 51ºÚÁϳԹÏÍø, International Journal of Applied Biology and Pharmaceutical Technology 51ºÚÁϳԹÏÍø, Journal of Pharmaceutical Microbiology, Clinical & Medical Genomics 51ºÚÁϳԹÏÍø, The New England Journal of Medicine, Journal of General Virology, Journal of Medical Microbiology

Immunogenicity of biopharmaceuticals